3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

C15H17N5 — CID 176981714

IUPAC3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
SMILESCC(C)c1ccc2nc(-c3cccnc3N)n(C)c2n1
InChIInChI=1S/C15H17N5/c1-9(2)11-6-7-12-15(18-11)20(3)14(19-12)10-5-4-8-17-13(10)16/h4-9H,1-3H3,(H2,16,17)
InChIKeyQPQQYHAOZAVHTM-UHFFFAOYSA-N
MW267.34 g/mol
LogP2.74
Rot. Bonds2

About 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (PubChem CID 176981714) has the molecular formula C15H17N5 and a molecular weight of 267.34 g/mol. Its IUPAC name is 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine.

Molecular Properties

Compound Name3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
PubChem CID176981714
Molecular FormulaC15H17N5
Molecular Weight267.34 g/mol
Exact Mass267.15
IUPAC Name3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
SMILESCC(C)c1ccc2nc(-c3cccnc3N)n(C)c2n1
InChIInChI=1S/C15H17N5/c1-9(2)11-6-7-12-15(18-11)20(3)14(19-12)10-5-4-8-17-13(10)16/h4-9H,1-3H3,(H2,16,17)
InChIKeyQPQQYHAOZAVHTM-UHFFFAOYSA-N
XLogP2.74
TPSA69.62 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500267.34
LogP ≤ 52.74
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(3-chloro-5-propan-2-yloxyimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
CID 174278002
3-(3-methoxyimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
CID 174278837
2-(2-amino-3-pyridinyl)-3-chloro-N-methylimidazo[4,5-b]pyridin-5-amine
CID 174279256
2-methyl-6-propan-2-yl-3-pyridin-2-ylpyridine
CID 134286166
ethane;3-[3-(4-methylphenyl)-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 171068731
3-[3-[4-[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]-5-(6-propan-2-yl-3-pyridinyl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 171599545
3-[3-hydroxy-5-(oxetan-3-yl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 174277886
3-[3-(4-methoxyphenyl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 58345186
3-[3-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 58345030
3-[3-[4-(chloromethyl)phenyl]-5-(5-propan-2-yl-2-pyridinyl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 177317072
3-[5-(4-chlorophenyl)-3-(4-methylphenyl)imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine;ethane
CID 171494402
3-[5-[2-(difluoromethyl)triazol-4-yl]-3-hydroxyimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
CID 174282893

Frequently Asked Questions

What is the IUPAC name of 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine?
The IUPAC name of 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (CID 176981714) is 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine.
What is the SMILES notation for 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine?
The canonical SMILES for 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine is CC(C)c1ccc2nc(-c3cccnc3N)n(C)c2n1.
What is the InChIKey of 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine?
The InChIKey is QPQQYHAOZAVHTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17N5/c1-9(2)11-6-7-12-15(18-11)20(3)14(19-12)10-5-4-8-17-13(10)16/h4-9H,1-3H3,(H2,16,17).
What are the key properties of 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine?
3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine has a molecular weight of 267.34 g/mol, XLogP of 2.74, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3-methyl-5-propan-2-ylimidazo[4,5-b]pyridin-2-yl)pyridin-2-amine is sourced from PubChem (CID 176981714), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).